NCT04398446View on ClinicalTrials.gov

Effect of Hemp-CBD on Patients With CIPN

PHASE2UnknownINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 27, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

April 1, 2023

Conditions
Chemotherapy-induced Peripheral NeuropathyColorectal Cancer Stage IIColorectal Cancer Stage IIIBreast CancerOvarian CancerUterine CancerPancreatic Cancer
Interventions
DRUG

Hemp-based CBD

3x Daily dosing for 12 weeks

OTHER

Placebo oral tablet

3x Daily dosing for 12 weeks

Trial Locations (1)

19096

Lankenau Medical Center, Wynnewood

Sponsors

Lead Sponsor

Main Line Health
All Listed Sponsors
collaborator

Ananda Hemp, Inc.

UNKNOWN

lead

Main Line Health

OTHER